Resistance to second-line drugs in multidrug-resistant tuberculosis - Authors' reply

Lancet. 2013 Feb 23;381(9867):626. doi: 10.1016/S0140-6736(13)60343-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents